Drug intelligence / Profile preview

allylestrenol

Development stage
Unknown
Lead developer
Gedeon Richter
Modality
Small Molecules
Administration
Oral
01

Overview

Allylestrenol is a synthetic progestogen (progestin) structurally related to progesterone, used primarily to prevent premature labor and recurrent or threatened miscarriage in pregnant women. It acts as an agonist of the progesterone receptor, supporting pregnancy by promoting endometrial receptivity for embryo implantation, maintaining the uterine lining, and relaxing uterine smooth muscle. Its mechanism of action is multimodal: it stimulates trophoblastic function (enhancing production of human chorionic gonadotropin and thus endogenous progesterone), exerts placentotropic effects, and has β2-adrenergic activity that relaxes myometrial muscle to inhibit uterine contractions. Allylestrenol is metabolized in the liver (mainly via CYP3A4), with a biological half-life of several hours; its main active metabolite is 17α-allyl-19-nortestosterone[1][2][3][6][8]. The drug has little estrogenic or androgenic activity compared to other 19-nortestosterone derivatives.

Brand names
GestinAstanolProlin ALutaninNidanolPregdotFetugardNidagestProfarRensureArandalAroserineCobarenolElmolanGravynonMaintane TabPerselinPregnolinTurinal
Other names
allylestrenol
02

Targets

PR (Progesterone receptor)

Beyond the preview

Go deeper on allylestrenol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on allylestrenol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call